메뉴 건너뛰기
New England Journal of Medicine
Volumn 359, Issue 2, 2008, Pages 210-212
Duration of survival in patients with myeloma treated with thalidomide
Author keywords

[No Author keywords available]
Indexed keywords

THALIDOMIDE;
EID: 46949085949     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc0801352     Document Type: Letter
Times cited : (9)
References (3)
  • 1
    • 33644833147 scopus 로고    scopus 로고
    • Thalidomide and hematopoietic-cell transplantation for multiple myeloma
    • Barlogie B, Tricot G, Anaissie E, et al. Thalidomide and hematopoietic-cell transplantation for multiple myeloma. N Engl J Med 2006;354:1021-30.
    • (2006) N Engl J Med , vol.354 , pp. 1021-1030
    • Barlogie, B.1    Tricot, G.2    Anaissie, E.3
  • 2
    • 0038495926 scopus 로고    scopus 로고
    • Continuous absence of metaphase-defined cytogenetic abnormalities, especially of chromosome 13 and hypodiploidy, ensures long-term survival in multiple myeloma treated with Total Therapy I: Interpretation in the context of global gene expression
    • Shaughnessy J, Jacobson J, Sawyer J, et al. Continuous absence of metaphase-defined cytogenetic abnormalities, especially of chromosome 13 and hypodiploidy, ensures long-term survival in multiple myeloma treated with Total Therapy I: interpretation in the context of global gene expression. Blood 2003;101:3849-56.
    • (2003) Blood , vol.101 , pp. 3849-3856
    • Shaughnessy, J.1    Jacobson, J.2    Sawyer, J.3
  • 3
    • 85031382140 scopus 로고    scopus 로고
    • Making progress in treating multiple myeloma with total therapies: Issue of complete remission and more
    • in press
    • Barlogie B, van Rhee F, Shaughnessy JD Jr, Anaissie E, Crowley J. Making progress in treating multiple myeloma with total therapies: issue of complete remission and more. Leukemia (in press).
    • Leukemia
    • Barlogie, B.1    van Rhee, F.2    Shaughnessy Jr, J.D.3    Anaissie, E.4    Crowley, J.5

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.